Page 17 - Read Online

Brown. Rare Dis Orphan Drugs J. 2025;4:21 https://dx.doi.org/10.20517/rdodj.2025.14 Page 13 of 15

11. McLean DT, Meudt JJ, Lopez Rivera LD, et al. Single-cell RNA sequencing of neurofibromas reveals a tumor microenvironment
favorable for neural regeneration and immune suppression in a neurofibromatosis type 1 porcine model. Front Oncol.
2023;13:1253659. DOI PubMed PMC
12. Nagrani NS, Bhawan J. Histopathological variants of cutaneous neurofibroma: a compendious review. Dermatopathology. 2022;10:1-
19. DOI PubMed PMC
13. Peltonen J, Penttinen R, Larjava H, Aho HJ. Collagens in neurofibromas and neurofibroma cell cultures. Ann N Y Acad Sci.
1986;486:260-70. DOI PubMed
14. Brosseau JP, Sathe AA, Wang Y, et al. Human cutaneous neurofibroma matrisome revealed by single-cell RNA sequencing. Acta
Neuropathol Commun. 2021;9:11. DOI PubMed PMC
15. Jiang C, McKay RM, Le LQ. Tumorigenesis in neurofibromatosis type 1: role of the microenvironment. Oncogene. 2021;40:5781-7.
DOI PubMed PMC
16. Harigai R, Sakai S, Nobusue H, et al. Tranilast inhibits the expression of genes related to epithelial-mesenchymal transition and
angiogenesis in neurofibromin-deficient cells. Sci Rep. 2018;8:6069. DOI PubMed PMC
17. Chen P, Cescon M, Megighian A, Bonaldo P. Collagen VI regulates peripheral nerve myelination and function. FASEB J.
2014;28:1145-56. DOI PubMed
18. Chen P, Cescon M, Zuccolotto G, et al. Collagen VI regulates peripheral nerve regeneration by modulating macrophage recruitment
and polarization. Acta Neuropathol. 2015;129:97-113. DOI
19. Cescon M, Gregorio I, Eiber N, et al. Collagen VI is required for the structural and functional integrity of the neuromuscular junction.
Acta Neuropathol. 2018;136:483-99. DOI
20. Cescon M, Gattazzo F, Chen P, Bonaldo P. Collagen VI at a glance. J Cell Sci. 2015;128:3525-31. DOI
21. Cescon M, Rampazzo E, Bresolin S, et al. Collagen VI sustains cell stemness and chemotherapy resistance in glioblastoma. Cell Mol
Life Sci. 2023;80:233. DOI PubMed PMC
22. Jiang C, Kumar A, Yu Z, et al. Basement membrane proteins in extracellular matrix characterize NF1 neurofibroma development and
response to MEK inhibitor. J Clin Invest. 2023:133. DOI
23. Williams L, Layton T, Yang N, Feldmann M, Nanchahal J. Collagen VI as a driver and disease biomarker in human fibrosis. FEBS J.
2022;289:3603-29. DOI
24. Wang WN, Koguchi-Yoshioka H, Nimura K, et al. Distinct transcriptional profiles in the different phenotypes of neurofibroma from
the same subject with neurofibromatosis 1. J Invest Dermatol. 2024;144:133-141.e4. DOI
25. Castagnaro S, Gambarotto L, Cescon M, Bonaldo P. Autophagy in the mesh of collagen VI. Matrix Biol. 2021;100-101:162-72. DOI
PubMed
26. Silver FH. The role of connections between cellular and tissue mechanical elements and the importance of applied energy in
mechanotransduction in cancerous tissue. Biomolecules. 2025;15:457. DOI PubMed PMC
27. Lu P, Chen Z, Wu M, et al. Type I collagen extracellular matrix facilitates nerve regeneration via the construction of a favourable
microenvironment. Burns Trauma. 2024;12:tkae049. DOI PubMed PMC
28. Li X, Shepard HM, Cowell JA, et al. Parallel accumulation of tumor hyaluronan, collagen, and other drivers of tumor progression. Clin
Cancer Res. 2018;24:4798-807. DOI PubMed PMC
29. Rømer AMA, Thorseth ML, Madsen DH. Immune modulatory properties of collagen in cancer. Front Immunol. 2021;12:791453. DOI
PubMed PMC
30. Henke E, Nandigama R, Ergün S. Extracellular matrix in the tumor microenvironment and its impact on cancer therapy. Front Mol
Biosci. 2019;6:160. DOI PubMed PMC
31. Huson SM, Harper PS, Compston DA. Von Recklinghausen neurofibromatosis: a clinical and population study in south-east Wales.
Brain. 1988;111:1355-81. DOI
32. Duong TA, Bastuji-Garin S, Valeyrie-Allanore L, Sbidian E, Ferkal S, Wolkenstein P. Evolving pattern with age of cutaneous signs in
neurofibromatosis type 1: a cross-sectional study of 728 patients. Dermatology. 2011;222:269-73. DOI PubMed
33. Cannon A, Chen MJ, Li P, et al. Cutaneous neurofibromas in neurofibromatosis type I: a quantitative natural history study. Orphanet J
Rare Dis. 2018;13:31. DOI PubMed PMC
34. Dugoff L, Sujansky E. Neurofibromatosis type 1 and pregnancy. Am J Med Genet. 1996;66:7-10. DOI PubMed
35. Geller M, Mezitis SG, Nunes FP, et al. Progesterone and estrogen receptors in neurofibromas of patients with NF1. Clin Med Pathol.
2008;1:93-7. DOI PubMed PMC
36. Fishbein L, Zhang X, Fisher LB, et al. In vitro studies of steroid hormones in neurofibromatosis 1 tumors and Schwann cells. Mol
Carcinog. 2007;46:512-23. DOI
37. Pennanen P, Peltonen S, Kallionpää RA, Peltonen J. The effect of estradiol, testosterone, and human chorionic gonadotropin on the
+/- -/-
proliferation of Schwann cells with NF1 or NF1 genotype derived from human cutaneous neurofibromas. Mol Cell Biochem.
2018;444:27-33. DOI PubMed
38. Lammert M, Mautner VF, Kluwe L. Do hormonal contraceptives stimulate growth of neurofibromas? BMC Cancer. 2005;5:16. DOI
PubMed PMC
39. Cannon A, Jarnagin K, Korf B, et al. Clinical trial design for cutaneous neurofibromas. Neurology. 2018;91:S31-7. DOI PubMed
PMC
40. Zhu B, Zheng T, Wang W, et al. Genotype-phenotype correlations of neurofibromatosis type 1: a cross-sectional study from a large